Vaccine-delivering nanoparticles may help fight HIV, malariaFebruary 23rd, 2011 - 5:10 pm ICT by ANI
London, Feb 23 (ANI): Engineers at MIT have come up with a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria.
The new particles consist of concentric fatty spheres that can carry synthetic versions of proteins normally produced by viruses. These synthetic particles elicit a strong immune response - comparable to that produced by live virus vaccines - but should be much safer, says Darrell Irvine, author of the paper and an associate professor of materials science and engineering and biological engineering.
Such particles could help scientists develop vaccines against cancer as well as infectious diseases. In collaboration with scientists at the Walter Reed Army Institute of Research, Irvine and his students are now testing the nanoparticles’ ability to deliver an experimental malaria vaccine in mice.
Vaccines protect the body by exposing it to an infectious agent that primes the immune system to respond quickly when it encounters the pathogen again. In many cases, such as with the polio and smallpox vaccines, a dead or disabled form of the virus is used. Other vaccines, such as the diphtheria vaccine, consist of a synthetic version of a protein or other molecule normally made by the pathogen.
When designing a vaccine, scientists try to provoke at least one of the human body’s two major players in the immune response: T cells, which attack body cells that have been infected with a pathogen; or B cells, which secrete antibodies that target viruses or bacteria present in the blood and other body fluids.
For diseases in which the pathogen tends to stay inside cells, such as HIV, a strong response from a type of T cell known as “killer” T cell is required. The best way to provoke these cells into action is to use a killed or disabled virus, but that cannot be done with HIV because it’s difficult to render the virus harmless.
To get around the danger of using live viruses, scientists are working on synthetic vaccines for HIV and other viral infections such as hepatitis B. However, these vaccines, while safer, do not elicit a very strong T cell response.
Importantly, the particles also elicit a strong antibody response. Niren Murthy, associate professor at Georgia Institute of Technology, says the new particles represent “a fairly large advance,” though he says that more experiments are needed to show that they can elicit an immune response against human disease, in human subjects. “There’s definitely enough potential to be worth exploring it with more sophisticated and expensive experiments,” he says.
The work has been described in the Feb. 20 issue of Nature Materials. (ANI)
- Vaccines to boost immunity where it counts - Jan 23, 2012
- New findings bring scientists closer to an effective HIV vaccine - Jan 15, 2011
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Hepatitis C vaccine undergoing trials - Aug 16, 2012
- Virus-like particle vaccine could offer protection against chikungunya virus - Jan 29, 2010
- Universal influenza vaccine 'on the anvil' - Dec 07, 2010
- Scientists closer to developing anti-malaria shot - Aug 06, 2012
- Tweaking antibody could lead to vaccine against HIV - May 08, 2011
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- New cell type boosts immunity to infection - Nov 30, 2011
- Unearthing Of Antibodies Could Assist The Discovery Of An AIDS Vaccine - Jul 09, 2010
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Experimental vaccine shows promise against chikungunya - Mar 05, 2010
- Antibodies that prevent HIV from infecting human cells found - Jul 09, 2010
Tags: b cells, biological engineering, body cells, body fluids, collaboration with scientists, diphtheria vaccine, infectious agent, infectious diseases, london feb, malaria vaccine, materials science and engineering, nanoparticle, synthetic version, synthetic versions, t cells, target, virus vaccines, walter reed army, walter reed army institute, walter reed army institute of research